Product Information
BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Epic Pharma LLC, priced at $0.1046 per EA under NDC 42806008301. Its NADAC has been published 359 times since Oct 9, 2019.
FDA first approved this application on Apr 16, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Epic Pharma LLCNDC
42806008301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208972FDA Approved
4/16/2019
TE Code
AB
On Market Since
4/17/2019
Price Statistics
The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 359 times since Oct 9, 2019, and over the history we have for it it has declined 72.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1046 per EA |
|---|---|
| All-time high | $0.3988 (Apr 15, 2020) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1212 |
| 52-week low | $0.1046 |
| Median price | $0.1624 |
| Average price | $0.2011 |
| Largest weekly change | -42.2% (Nov 20, 2024) |
| Weeks tracked | 359 |
| Tracking since | Oct 9, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Epic Pharma LLC, is $0.1046 per EA (NDC 42806008301), effective Aug 19, 2026.
How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 72.6%. It has been tracked across 359 weekly CMS publications since Oct 9, 2019.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?
Since Oct 9, 2019, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.3988 (Apr 15, 2020), with a median of $0.1624 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUSPIRONE HCL 7.5 MG TABLET, is $0.1039 per EA — about 1% below BUSPIRONE HCL 7.5 MG TABLET.
Who manufactures BUSPIRONE HCL 7.5 MG TABLET?
BUSPIRONE HCL 7.5 MG TABLET (NDC 42806008301) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.